Financial Results
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2021 Financial Results
Samsung Biologics
PR-M01-22-16Jan 24, 2022
Diversification
Product Diversification Through Expansion into the Animal Health Market
Tim Tyson
TriRx Pharmaceutical Services
PAP-Q4-20-CL-026Dec 09, 2020